002294.SZ
Price:
$45
Market Cap:
$50.17B
Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines for cardiovascular, anti-diabetic, antineoplastic, and orthopedic therapeutic in China. It offers cardiovascular and cerebrovascular products, such as allisartan isoproxil, benazepril hydrochloride, desloratadine, and clopidogrel bisulfate tablets, as well as bivalirudin and pamidronate disodium injections; recombinant SeV-hFGF2/dF Injection for the treatment of diabetic foot disease; and anti-tumor and orthopedics medicines. The company also provides anti-infection products comprising cefonicid sodium, ceftazidime, ceftriaxone sodium, cefonicid sodium, cefminox sodium, cefurox...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
2009-09-10
Stock Exchange
SHZ
Ticker
002294.SZ
According to Shenzhen Salubris Pharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 7.06%. This represents a change of 300.14% compared to the average of 1.77% of the last 4 quarters.
The mean historical ROE of Shenzhen Salubris Pharmaceuticals Co., Ltd. over the last ten years is 14.04%. The current 7.06% ROE has changed -49.71% with respect to the historical average. Over the past ten years (40 quarters), 002294.SZ's ROE was at its highest in in the June 2015 quarter at 7.75%. The ROE was at its lowest in in the December 2020 quarter at -3.75%.
Average
14.04%
Median
9.52%
Minimum
1.10%
Maximum
27.58%
Discovering the peaks and valleys of Shenzhen Salubris Pharmaceuticals Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 501.25%
Maximum Annual ROE = 27.58%
Minimum Annual Increase = -89.97%
Minimum Annual ROE = 1.10%
Year | ROE | Change |
---|---|---|
2024 | 6.90% | -4.54% |
2023 | 7.23% | -9.84% |
2022 | 8.02% | 20.76% |
2021 | 6.64% | 501.25% |
2020 | 1.10% | -89.97% |
2019 | 11.02% | -49.66% |
2018 | 21.89% | -8.73% |
2017 | 23.99% | -7.92% |
2016 | 26.05% | -5.55% |
2015 | 27.58% | 0.02% |
The current ROE of Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.39%
5-year avg
5.98%
10-year avg
14.04%
Shenzhen Salubris Pharmaceuticals Co., Ltd.’s ROE is less than Huadong Medicine Co., Ltd (15.68%), less than Jiangsu Yanghe Brewery Joint-Stock Co., Ltd. (8.12%), less than Hualan Biological Engineering Inc. (9.70%), less than Dong-E-E-Jiao Co.,Ltd. (15.81%), less than Yunnan Baiyao Group Co.,Ltd (12.50%),
Company | ROE | Market cap |
---|---|---|
15.68% | $68.78B | |
8.12% | $98.70B | |
9.70% | $29.08B | |
15.81% | $33.01B | |
12.50% | $99.02B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shenzhen Salubris Pharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Shenzhen Salubris Pharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Shenzhen Salubris Pharmaceuticals Co., Ltd.'s ROE?
How is the ROE calculated for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)?
What is the highest ROE for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)?
What is the 3-year average ROE for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)?
What is the 5-year average ROE for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)?
How does the current ROE for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) compare to its historical average?